scb-1019t
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 15, 2025 (NCT06666179)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06984094 | Phase 1 | Jun 18, 2025 | Clover Biopharmaceuticals |
| NCT06843317 | Phase 1 | Mar 21, 2025 | Clover Biopharmaceuticals |
| NCT06666179 | Phase 1 | Mar 15, 2025 | Clover Biopharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clover Biopharmaceuticals | For profit | 3 | 3 | 1 | 2025 |
1 organizations
Page 1 / 1